Form 4 for PALI PALISADE BIO, INC.
Accepted 2024-03-12 00:00:00 ET · period of report 2024-03-11 · accession 0001493152-24-009709 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-12 | 2024-03-11 | PALI | Finley John David | CEO, CFO, Dir | M - OptEx | $0.00 | +5,558 | 96.8K | +6% | $0 |
| D | 2024-03-12 | 2024-03-11 | PALI | Finley John David | CEO, CFO, Dir | M - OptEx | — | -5,558 | 50.0K | -10% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.01 | 2024-03-11 | M | A | 5,558 | $0.00 | 96,849 | D | — | — | (F1) Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on June 11, 2023. |
| 2 | Derivative | Restricted Stock Units | 2024-03-11 | M | D | 5,558 | — | 50,025 | D | — · — to — | 5,558 Common Stock | (F4) This restricted stock unit was granted on June 11, 2023, and 5,558 restricted stock units subject to the award vested on March 11, 2024, and an additional 50,025 restricted stock units will vest in equal quarterly installments over the remaining portion of the three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting. (F3) Each restricted stock unit represents the right to receive, at settlement, one share of common stock. |